| 000 | 01859 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515211912.0 | ||
| 264 | 0 | _c20100325 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1095-9203 | ||
| 024 | 7 |
_a10.1126/science.1177319 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIto, Takumi | |
| 245 | 0 | 0 |
_aIdentification of a primary target of thalidomide teratogenicity. _h[electronic resource] |
| 260 |
_bScience (New York, N.Y.) _cMar 2010 |
||
| 300 |
_a1345-50 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdaptor Proteins, Signal Transducing |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCarrier Proteins _xmetabolism |
| 650 | 0 | 4 | _aChick Embryo |
| 650 | 0 | 4 |
_aCullin Proteins _xmetabolism |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xmetabolism |
| 650 | 0 | 4 |
_aEmbryo, Nonmammalian _xdrug effects |
| 650 | 0 | 4 |
_aEmbryonic Development _xdrug effects |
| 650 | 0 | 4 |
_aFibroblast Growth Factors _xgenetics |
| 650 | 0 | 4 |
_aForelimb _xabnormalities |
| 650 | 0 | 4 | _aGene Expression Regulation, Developmental |
| 650 | 0 | 4 | _aHeLa Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMutant Proteins _xmetabolism |
| 650 | 0 | 4 |
_aPeptide Hydrolases _xgenetics |
| 650 | 0 | 4 |
_aTeratogens _xmetabolism |
| 650 | 0 | 4 |
_aThalidomide _xmetabolism |
| 650 | 0 | 4 |
_aUbiquitin-Protein Ligases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aUbiquitination |
| 650 | 0 | 4 |
_aZebrafish _xembryology |
| 650 | 0 | 4 |
_aZebrafish Proteins _xgenetics |
| 700 | 1 | _aAndo, Hideki | |
| 700 | 1 | _aSuzuki, Takayuki | |
| 700 | 1 | _aOgura, Toshihiko | |
| 700 | 1 | _aHotta, Kentaro | |
| 700 | 1 | _aImamura, Yoshimasa | |
| 700 | 1 | _aYamaguchi, Yuki | |
| 700 | 1 | _aHanda, Hiroshi | |
| 773 | 0 |
_tScience (New York, N.Y.) _gvol. 327 _gno. 5971 _gp. 1345-50 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1126/science.1177319 _zAvailable from publisher's website |
| 999 |
_c19590283 _d19590283 |
||